New targeted drug tested for Tough-to-Treat lung cancers
NCT ID NCT05652868
Summary
This study tested a new type of targeted cancer drug called MYTX-011 in people with advanced non-small cell lung cancer (NSCLC) that had progressed after standard treatments. The main goals were to find a safe dose and see if the drug could shrink tumors, especially in patients whose cancer has a specific genetic marker (cMET). The trial was terminated and is no longer enrolling participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Hopital de la Timone
Marseille, France
-
Atlantic Health System
Morristown, New Jersey, 07960, United States
-
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
-
Blacktown Hospital
Blacktown, New South Wales, 2148, Australia
-
Cancer Research SA
Adelaide, South Australia, 5011, Australia
-
Centre Léon Bérard - Lyon
Lyon, France
-
Chris O'Brien Lifehouse
Camperdown, New South Wales, 2050, Australia
-
Chungbuk National Univ. Hospital
Incheon, 21565, South Korea
-
Churchill Hospital - Oxford University Hospitals
Oxford, OX3 7LJ, United Kingdom
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98019, United States
-
Gachon University
Seongnam, South Korea
-
Gustave Roussy Institute
Villejuif, France
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Hospital Clinico Universitario de Valencia
Valencia, Spain
-
Hospital Quirónsalud Málaga
Málaga, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Lozano Blesa
Zaragoza, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Spain
-
INSTITUT Curie (lead)
Paris, France
-
Institut Bergonié-Bordeaux
Bordeaux, France
-
Institut de Cancérologie de l'Ouest (ICO institute)-St Herblain
Nantes, France
-
Instituto Oncológico Dr Rosell (IOR) - Hospital Univ. Dexeus
Barcelona, Spain
-
Kosin Univ. Gospel Hospital
Busan, South Korea
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
MUSC Hollings Cancer Center
Charleston, South Carolina, 29425, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
NEXT Oncology
Fairfax, Virginia, 22031, United States
-
NYU Langone Medical Center
New York, New York, 10016, United States
-
National Cancer Center
Seoul, 03080, South Korea
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Cancer Centre
Taipei, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
National Taiwan University Hospital Hsin-Chu Branch
Zhubei, 302058, Taiwan
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Newcastle upon Tyne Hospital (NHS)
Newcastle, United Kingdom
-
Oncopole Claudius Regaud, IUCT-Oncopole
Toulouse, France
-
Piedmont Physicians Medical Oncology
Atlanta, Georgia, 30318, United States
-
Queen Elizabeth Hospital
Adelaide, South Australia, 5000, Australia
-
START Barcelona-HM CIOCC Early Phase Program
Barcelona, Spain
-
START Centro Integral Oncologico Calra Campal
Madrid, Spain
-
START Madrid-FJD, Hospital Fundación Jiménez Díaz
Madrid, Spain
-
Samsung Medical Center
Seoul, South Korea
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Seoul National University Hospital
Seoul, MA, 01886, South Korea
-
Severance Hospital
Seoul, South Korea
-
St. Vincent Hospital
Suwon, South Korea
-
Taichung Veterans General Hospital
Taichung, MA, 01886, Taiwan
-
Taipei Medical University Hospital
Taipei, 110301, Taiwan
-
UCLA
Los Angeles, California, 90095, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
University College London Hospitals NHS Foundation Trust
London, W1T 7HA, United Kingdom
-
University of California San Diego
La Jolla, California, 92037, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
-
Winship Cancer Institute, Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.